|
Clinical Population |
Measure / |
Inclusion criteria |
Screening, test or treatment needed |
|
ALL ADULTS |
Access to preventive/ ambulatory health services [A] |
Ages 20-44. 45-64, and 65 and older |
An ambulatory or preventive care visit during the last three years |
|
Smoking and Tobacco Use Cessation [S] |
Age 18 and older |
Survey questions: current smoker or tobacco user
|
|
|
Aspirin Use and Discussion [S] |
Women: Age 55 to 79 Men: Age 45 to 79 |
Survey question: Asked if currently taking aspirin Women - with at least two risk factors for cardiovascular disease Men age 45 to 64 - with at least one risk factor for cardiovascular disease Men age 65 to 79 - regardless of risk factor |
|
|
Colorectal cancer screening [H] |
Age 50 - 75 |
One or more of the following appropriate colorectal cancer screenings: [fecal occult blood test (three-card specimen) (in the last year)], flexible sigmoidoscopy (in the last 5 years), or colonoscopy (in the last 10 years) |
|
|
Flu shots for adults [S] |
Age 50 to 64 Age 65 and older |
Survey question: Did the member get a flu shot at any location during the previous flu season? (Between September 1st and the date the survey is completed) |
|
|
Adult BMI Assessment [H] |
Age 18 to 74 |
An outpatient visit and had their body mass index (BMI) documented during the last two years. |
|
|
Medicare (HMO product SrCare) only
|
Osteoporosis Management in Women who had a fracture [A] |
Age 67 and older |
Women suffered a fracture, and who had either a bone mineral density (BMD) test or prescription for a drug to treat or prevent osteoporosis in the six months after the date of the fracture. |
|
Osteoporosis Testing in Older Women [S] |
Age 65 and older |
Survey question: Women report if they ever received a bone density test to check for osteoporosis. |
|
|
Glaucoma Screening in Older Adults [A] |
Age 65 and older |
Received a glaucoma eye exam by an eye care professional in the last two years. Exclude prior diagnosis of glaucoma or glaucoma suspect. |
|
|
Physical Activity in Older Adults [S] |
Age 65 and older |
Had a doctor's office visit in the past 12 months
|
|
|
Fall Risk Management [S] |
Age 65 and older |
Survey questions: Had a history of problems with balance, walking problems or a fall in the past 12 months
|
|
|
Urinary Incontinence in Older Adults [S] |
Age 65 and older |
Survey questions: Reported having a problem with urine leakage in the past six months
|
|
|
Pneumonia Vaccination Status for Older Adults [S] |
Age 65 and older |
Survey question: Have you ever received a pneumococcal vaccine. |
|
|
WOMEN & TEENAGE GIRLS |
Breast cancer screening [A] |
Age 40 - 69 |
At least one mammogram within the last two years. Excludes bilateral mastectomy. |
|
Cervical cancer screening [A] |
Age 21 - 64 |
At least one or more pap smears within three years. Excludes hysterectomy with no residual cervix. |
|
|
Chlamydia screening in young women [A] |
Sexually active women age 16-24 |
At least one screening test for Chlamydia within the past year |
|
|
Prenatal / post-partum care [H] |
Live birth from 11/6/08-11/5/09 |
|
|
|
CHILDREN & ADOLESCENTS
|
Childhood immunizations [H] |
Age 0 - 2 |
4 DTap, 3 IPV, 1 MMR, 3 HIB, 3 Hep B, 1 VZV, 4 PCV, 2 Hep A, 2 or 3 RV and 2 flu by age two DTap = Diphtheria - Tetanus - Pertussis / IPV = Polio / MMR = Measles - Mumps - Rubella / HIB = Haemophilus influenza type b / HEP B = Hepatitis B / VZV = Varicella (chickenpox) / PCV = Pneumococcal / Hep A = Hepatitis A / RV = Rotovirus / flu = influenza vaccine |
|
Adolescent immunizations [H] |
Age 11-13 |
Adolescents who received one meningococcal vaccine on or between the members 11th and 13th birthday and one tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap) or one tetanus, diphtheria toxoids vaccine (Td) on or between the member's 10th and 13th birthdays. |
|
|
Access to primary care physicians [A] |
Ages 12-24 months, 25 months - 6 years, 7-11 and 12-19 |
A visit with a primary care physician (PCP) each year |
|
|
Well-care visits within 1st 15 months of life [A] |
Age 0-15 months |
At least six well-child visits with a PCP by age 15 months. |
|
|
Well-care visits in the 3rd, 4th, 5th and 6th years of life [A] |
Age 3-6 |
At least one well-child visit with a PCP within the past year. |
|
|
Adolescent well-care visits [A] |
Age 12-21 |
At least one well-care visit with a PCP or OB/GYN within the past year. |
|
|
Weight Assessment Nutrition and Physical Activity [H] |
Age 3-17 |
An outpatient visit with a primary care practitioner or OB/GYN and evidence of BMI percentile documentation, counseling for nutrition and counseling for physical activity |
|
|
CARDIAC CARE Adults only
|
Persistence of Beta-Blocker Treatment after a Heart Attack [A] |
Heart attack patients age 18 and older |
Following a heart attack, member received a 135 - to 180-day course of treatment with a beta-blocker (Excludes history of asthma, hypotension, Heart Block greater than first degree, and sinus bradycardia) |
|
Cholesterol Management for Patients with Selected Cardiovascular Conditions [H] |
Selected cardiovascular diagnoses, age 18-75
|
Includes acute myocardial infarction, coronary artery bypass, percutaneous coronary interventions and ischemic vascular disease. |
|
|
Controlling High Blood Pressure (Hypertension) [H]
|
Age 18-85 with high blood pressure |
Systolic blood pressure less than 140 mmHg AND diastolic blood pressure less than 90 mmHg (use the last outpatient blood pressure in the calendar year) Includes members with diagnosis of hypertension noted in the medical record prior to June 30 of measurement year. |
|
|
DIABETICS Adults only
|
Comprehensive Diabetes Care [H] |
Members diagnosed with Type 1 or Type II diabetes, age 18-75 |
Each year, members with Type I or Type II diabetes should have:
|
|
RESPIRATORY
See also MEDICATION SECTION |
Use of Spirometry Testing in the Assessment and Diagnosis of Chronic Obstructive Pulmonary Disease (COPD) [A]
|
Age 40 and older. |
New diagnosis of newly active COPD who received appropriate spirometry testing to confirm the diagnosis.
|
|
MEDICATION
|
Annual Monitoring for Patients on Persistent Medications [A] |
Age 18 and older |
#1, 2, and 3: At least one serum potassium and either a serum creatinine or a blood urea nitrogen (BUN) test in the measurement year #4. At least one serum concentration level test specific to drug taken (i.e. a member on both phenytoin and valproic acid with a 180-days supply of each drug must separately show evidence of receiving drug serum concentration tests for each drug.
|
|
Use of Appropriate Medications for People with Persistent Asthma [A] |
Members with persistent asthma, age 5-50
|
Members with persistent asthma should receive a prescription medication acceptable as primary treatment for long-term control of asthma (persistent asthma = ANY of the following in the prior year - four prescriptions, one ER visit, one inpatient stay OR four outpatient visits for asthma treatment) |
|
|
Appropriate treatment for children with upper respiratory infection (URI) [A] |
Age 3 months - 18 years of age with diagnosis of URI |
Did not receive an antibiotic prescription on or within 3 days after the diagnosis of an upper respiratory infection ( antibiotics are NOT an appropriate treatment for this diagnosis) |
|
|
Appropriate testing for children with pharyngitis (sore throat) [A] |
Age 2-18 with diagnosis of pharyngitis |
Has been diagnosed with pharyngitis, received a prescription and received a group A streptococcus (strep) test within 3 days of the prescription |
|
|
Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis [A] |
Age 18 to 64 with diagnosis of Acute Bronchitis |
Did not receive an antibiotic prescription |
|
|
Pharmacotherapy Management of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation [A] |
Age 40 and older. |
An acute inpatient discharge or emergency department (ED) encounter for COPD exacerbation between January 1 and December 1 and where dispensed appropriate medications. Two rates are reported:
|
|
|
Use of High-Risk Medications in the Elderly [A]
|
Age 65 and older (Medicare only) |
Note: not all drugs in the categories below are included - there are specific medications for each category. Drug categories include: Antianxiety, antiemetics, analgesics, antihistamines, antipsychotic (typical), amphetamines, barbiturates, long-acting benzodiazepines, calcium channel blockers, gastrointestinal antispasmodics, Belladonna alkaloids, skeletal muscle relaxants, oral estrogens, oral hypoglycemics, narcotics, vasodilators, and others (androgens and anabolic steroids, thyroid drugs, and urinary anti-infectives). |
|
|
Potentially Harmful Drug-Disease Interactions in the Elderly [A] |
Age 65 and older (Medicare only) |
Dispensed an ambulatory prescription for a contraindicated medication, concurrent with or after the diagnosis of one of the following:
|
|
|
Rheumatoid Arthritis - Disease-Modifying Anti-Rheumatic Drug Therapy for Rheumatoid Arthritis [A] |
Age 18 and older |
Dispensed at least one ambulatory prescription for a disease modifying anti-rheumatic drug (DMARD) 5-Aminosalicylates, Alkylating agents, Aminoquinolines, Anti-rheumatics, Immunomodulators, Immunosuppressive agents or Tetracyclines. |
|
|
RADIOLOGY |
Use of Imaging Studies for Low Back Pain [A] |
Age 18 to 50 (Commercial only) |
Did not receive an imaging study within 28 days of a primary diagnosis of low back pain (plain x-ray, MRI or CT scan) Exclude cancer, trauma, IV drug abuse or neurologic impairment. |
|
BEHAVIORAL HEALTH CARE
|
Antidepressant Medication Management [A] |
Adults, age 18 and older, diagnosed with a new episode of depression & treated with an antidepressant drug |
|
|
Follow-up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication [A] |
Age 6 to 12, dispensed ADHD medication |
|
|
|
Follow-up visit after hospitalization for mental illness[A] |
Members, age 6 and older, discharged from an inpatient mental health hospitalization |
After hospitalization a outpatient visit is needed by a mental health practitioner
Note a Primary Care Physician visit does not count towards compliance. Mental health practitioner includes: A psychiatrist, psychologist, Master's degree in social work, RN certified as a psychiatric nurse or mental health clinical nurse specialist, Master's degree or doctoral degree in counseling, marital and family therapy. |
|
|
Initiation of alcohol and other drug (AOD) dependence treatment [A] |
Members aged 13 and older diagnosed with AOD dependence |
Initiation of treatment - AOD dependence who initiate treatment within 14 days of diagnosis through either:
|
|
|
Engagement of alcohol and other drug (AOD) dependence treatment [A] |
Members aged 13 and older diagnosed with AOD dependence |
An intermediate step between initially accessing care (initiation treatment) and completing a full course of treatment. This measure is designed to assess the degree to which members engage in treatment with two or more additional AOD services within 30 days after completing the Initiation treatment with any AOD diagnosis:
|
Source: HEDIS®2011 Technical Specifications Volume Two © National Committee for Quality Assurance (NCQA)
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA)
"Reproduced with permission from the HEDIS 2011 Volume 2 Technical Specifications by the National Committee for Quality Assurance (NCQA). To purchase copies of this publication, contact NCQA Customer Support at 888-275-7585 or www.ncqa.org/publications. HEDIS®is a registered trademark of NCQA. NCQA has not reviewed and does not endorse this reproduction."